PATENT CLAIM ANALYSIS

Application Number: 15903725
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["436", "501000"]

Abstract:
Devices, solutions and method capable of quantifying a clinically significant amount of antibodies within a plasma sample obtained from an individual by quantifying binding between antibodies within the sample and microbial proteins are disclosed.

Claim (Index 5):
The method of  claim 1 , further comprising:\n exposing the sample to a second microbial protein homologous to a second human protein, the second microbial protein different than the first microbial protein and comprising at least a portion of at least one of RPOB, EF-G, hsp65 ATP5a and EF-Tu; quantifying binding between antibodies within the sample and the second microbial protein; and contrasting the quantified binding between the antibodies and the second microbial protein to a second threshold value.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.24138
- Patent Class: 436.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12047131', '13732434', '13060399', '13459192', '11786193']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6734738704256292
- 35 USC 102 Novelty (BERT): 0.4742685134232915
- Combined Prediction Score: 0.6535533347253955
- Mean Citation Score: 210.28351400000005
- Max Citation Score: 217.84291
- Similarity Product: 162.62411139842212

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test